Latest Insider Transactions at Alector, Inc. (ALEC)
This section provides a real-time view of insider transactions for Alector, Inc. (ALEC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Alector, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Alector, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 01
2024
|
Gary Romano Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
184,380
+33.61%
|
-
|
|
Oct 01
2024
|
Arnon Rosenthal Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
610,500
+19.26%
|
-
|
|
Oct 01
2024
|
Sara Kenkare Mitra President and Head of R&D |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+33.64%
|
-
|
|
Oct 01
2024
|
Marc Grasso Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
216,400
+38.4%
|
-
|
|
Sep 03
2024
|
Marc Grasso Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,297
-5.29%
|
$29,188
$4.88 P/Share
|
|
Sep 03
2024
|
Gary Romano Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
8,478
-4.5%
|
$33,912
$4.88 P/Share
|
|
Sep 03
2024
|
Sara Kenkare Mitra President and Head of R&D |
SELL
Open market or private sale
|
Direct |
13,926
-4.56%
|
$55,704
$4.88 P/Share
|
|
Sep 03
2024
|
Arnon Rosenthal Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
26,499
-1.34%
|
$105,996
$4.88 P/Share
|
|
Aug 22
2024
|
Richard H Scheller |
SELL
Open market or private sale
|
Direct |
44,250
-55.84%
|
$221,250
$5.16 P/Share
|
|
Aug 12
2024
|
Kristine Yaffe |
SELL
Open market or private sale
|
Direct |
5,000
-6.88%
|
$25,000
$5.06 P/Share
|
|
Aug 12
2024
|
Paula Hammond |
SELL
Open market or private sale
|
Direct |
10,500
-14.85%
|
$52,500
$5.06 P/Share
|
|
Aug 02
2024
|
Richard H Scheller |
BUY
Grant, award, or other acquisition
|
Direct |
15,833
+23.75%
|
-
|
|
Jun 12
2024
|
Paula Hammond |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+33.11%
|
-
|
|
Jun 12
2024
|
David M. Wehner |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+23.28%
|
-
|
|
Jun 12
2024
|
Richard H Scheller |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+30.63%
|
-
|
|
Jun 12
2024
|
Elizabeth A. Garofalo |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+36.36%
|
-
|
|
Jun 12
2024
|
Kristine Yaffe |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+32.5%
|
-
|
|
Jun 12
2024
|
Louis J Lavigne Jr |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+33.11%
|
-
|
|
Jun 03
2024
|
Marc Grasso Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,920
-4.77%
|
$27,680
$4.8 P/Share
|
|
Jun 03
2024
|
Arnon Rosenthal Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
25,135
-1.26%
|
$100,540
$4.8 P/Share
|
|
Jun 03
2024
|
Sara Kenkare Mitra President and Head of R&D |
SELL
Open market or private sale
|
Direct |
13,206
-4.14%
|
$52,824
$4.8 P/Share
|
|
Jun 03
2024
|
Gary Romano Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
8,040
-4.1%
|
$32,160
$4.8 P/Share
|
|
May 29
2024
|
Polaris Venture Management Co. Vi, L.L.C. |
SELL
Other acquisition or disposition
|
Direct |
98,533
-100.0%
|
-
|
|
May 29
2024
|
Polaris Venture Management Co. Vi, L.L.C. |
BUY
Other acquisition or disposition
|
Direct |
98,533
+50.0%
|
-
|
|
May 29
2024
|
Polaris Venture Management Co. Vi, L.L.C. |
SELL
Other acquisition or disposition
|
Indirect |
500,000
-4.83%
|
-
|
|
Apr 30
2024
|
Polaris Venture Management Co. Vi, L.L.C. |
SELL
Other acquisition or disposition
|
Direct |
98,533
-100.0%
|
-
|
|
Apr 30
2024
|
Polaris Venture Management Co. Vi, L.L.C. |
BUY
Other acquisition or disposition
|
Direct |
98,533
+50.0%
|
-
|
|
Apr 30
2024
|
Polaris Venture Management Co. Vi, L.L.C. |
SELL
Other acquisition or disposition
|
Indirect |
500,000
-4.61%
|
-
|
|
Mar 19
2024
|
Errol B Desouza |
BUY
Grant, award, or other acquisition
|
Direct |
41,250
+50.0%
|
-
|
|
Mar 19
2024
|
Mark Altmeyer |
BUY
Grant, award, or other acquisition
|
Direct |
41,250
+50.0%
|
-
|
|
Mar 04
2024
|
Sara Kenkare Mitra President and Head of R&D |
SELL
Open market or private sale
|
Direct |
10,169
-3.09%
|
$61,014
$6.92 P/Share
|
|
Mar 04
2024
|
Gary Romano Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,001
-2.97%
|
$36,006
$6.92 P/Share
|
|
Mar 04
2024
|
Arnon Rosenthal Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
18,837
-0.93%
|
$113,022
$6.92 P/Share
|
|
Mar 04
2024
|
Marc Grasso Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,716
-3.79%
|
$34,296
$6.92 P/Share
|
|
Dec 05
2023
|
Elizabeth A. Garofalo |
SELL
Bona fide gift
|
Direct |
9,459
-26.49%
|
-
|
|
Dec 04
2023
|
Sara Kenkare Mitra President and Head of R&D |
SELL
Open market or private sale
|
Direct |
12,519
-3.67%
|
$62,595
$5.56 P/Share
|
|
Dec 04
2023
|
Arnon Rosenthal Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
23,831
-1.17%
|
$119,155
$5.56 P/Share
|
|
Dec 04
2023
|
Gary Romano Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,035
-2.43%
|
$25,175
$5.56 P/Share
|
|
Dec 04
2023
|
Marc Grasso Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,574
-2.95%
|
$22,870
$5.56 P/Share
|
|
Oct 01
2023
|
Arnon Rosenthal Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
397,600
+16.29%
|
-
|
|
Oct 01
2023
|
Sara Kenkare Mitra President and Head of R&D |
BUY
Grant, award, or other acquisition
|
Direct |
163,600
+32.39%
|
-
|
|
Oct 01
2023
|
Marc Grasso Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
123,000
+44.21%
|
-
|
|
Oct 01
2023
|
Gary Romano Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
108,000
+34.25%
|
-
|
|
Sep 11
2023
|
Polaris Venture Management Co. Vi, L.L.C. |
SELL
Open market or private sale
|
Indirect |
500,000
-4.4%
|
$3,000,000
$6.0 P/Share
|
|
Sep 11
2023
|
Terrance Mcguire Director |
SELL
Open market or private sale
|
Indirect |
500,000
-4.4%
|
$3,000,000
$6.0 P/Share
|
|
Sep 05
2023
|
Marc Grasso Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,114
-3.34%
|
$5,570
$5.19 P/Share
|
|
Sep 05
2023
|
Gary Romano Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,771
-2.71%
|
$13,855
$5.19 P/Share
|
|
Sep 05
2023
|
Sara Kenkare Mitra President and Head of R&D |
SELL
Open market or private sale
|
Direct |
6,214
-3.37%
|
$31,070
$5.19 P/Share
|
|
Sep 05
2023
|
Arnon Rosenthal Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,647
-0.34%
|
$28,235
$5.19 P/Share
|
|
Aug 22
2023
|
Terrance Mcguire Director |
BUY
Other acquisition or disposition
|
Indirect |
111,666
+37.5%
|
-
|